ONTRUZANT Trademark

Trademark Overview

On Monday, November 17, 2014, a trademark application was filed for ONTRUZANT with the United States Patent and Trademark Office. The USPTO has given the ONTRUZANT trademark a serial number of 86456110. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 23, 2018. This trademark is owned by Merck Sharp & Dohme Corp.. The ONTRUZANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
ontruzant

General Information

Serial Number86456110
Word MarkONTRUZANT
Filing DateMonday, November 17, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 23, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 24, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, July 23, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 23, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, December 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2017EXTENSION 5 GRANTED
Monday, November 27, 2017EXTENSION 5 FILED
Monday, November 27, 2017TEAS EXTENSION RECEIVED
Wednesday, May 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 15, 2017EXTENSION 4 GRANTED
Monday, May 15, 2017EXTENSION 4 FILED
Monday, May 15, 2017TEAS EXTENSION RECEIVED
Saturday, December 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2016EXTENSION 3 GRANTED
Tuesday, December 6, 2016EXTENSION 3 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Thursday, July 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 6, 2016EXTENSION 2 GRANTED
Wednesday, June 1, 2016EXTENSION 2 FILED
Tuesday, July 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 1, 2016TEAS EXTENSION RECEIVED
Friday, December 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 2, 2015EXTENSION 1 GRANTED
Wednesday, December 2, 2015EXTENSION 1 FILED
Wednesday, December 2, 2015TEAS EXTENSION RECEIVED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 4, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Monday, November 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 20, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

ontruzant oncology preparations pharmaceutical